Cesarean myomectomy in modern obstetrics: More light and fewer shadows.
The study aim was to evaluate management of myomas during cesarean section, the pro and cons and the outcomes of cesarean myomectomy. Moreover, we tried to investigate the long-term outcomes of cesarean myomectomy. The authors conducted a literature review using scientific databases, focusing on the benefits and outcomes of cesarean myomectomy and the recent trends regarding this topic, and identified relevant articles, related references and other papers citing them. Despite the demonstrated advantages of cesarean myomectomy, postponed myomectomy after cesarean section was recommended in some instances. Apart from recent reports on the safety and feasibility of cesarean myomectomy, the current literature also describes serious complications of cesarean myomectomy, including even maternal death. This poses a question about the reported rate of complications: whether it is underestimated in common practice. Although some studies strongly suggest the safety of cesarean myomectomy, data on the long-term outcomes of cesarean myomectomy in women are lacking. The risk-benefit ratio of cesarean myomectomy should be re-evaluated in the new century, given the increasing patient age, incidence of myoma in pregnancy, and the wide use of assisted reproductive techniques.
Clinic of Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade, Serbia.|School of Medicine, University of Belgrade, Belgrade, Serbia.
Radmila
R
Sparić
Clinic of Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade, Serbia.|School of Medicine, University of Belgrade, Belgrade, Serbia.
Saša
S
Kadija
Clinic of Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade, Serbia.|School of Medicine, University of Belgrade, Belgrade, Serbia.
Aleksandar
A
Stefanović
Clinic of Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade, Serbia.|School of Medicine, University of Belgrade, Belgrade, Serbia.
Svetlana
S
Spremović Radjenović
Clinic of Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade, Serbia.|School of Medicine, University of Belgrade, Belgrade, Serbia.
Ivana
I
Likić Ladjević
Higher Education School of Professional Health Studies, Belgrade, Serbia.
Jela
J
Popović
International Translational Medicine and Biomodeling Research Group, Department of Applied Mathematics, Moscow Institute of Physics and Technology, Moscow State University, Dolgoprudny, Moscow, Russia.|Division of Experimental Endoscopic Surgery, Imaging, Technology and Minimally Invasive Therapy, Department of Obstetrics and Gynecology, Vito Fazzi Hospital, Piazzetta Muratore, Lecce, Italy.
Andrea
A
Tinelli
D002585:Cesarean Section / Q000009:adverse effects / Q000592:standards*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000601:surgery*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000601:surgery*; D063186:Uterine Myomectomy / Q000009:adverse effects / Q000592:standards*; D014594:Uterine Neoplasms / Q000601:surgery*
cesarean myomectomy; cesarean section; complication; myoma; outcome